Publication dates

All regions

Insulin Industry, July 2014 Market Reports from Top Publishers

You might be interested in: medical equipment, drug, therapeutics, more »


 
1-20 of about 400 reports for Insulin

Insulin Aspart  - Comprehensive patent search

Insulin Aspart - Comprehensive patent search

  • $ 10 118
  • Company report
  • July 2014
  • by Ark Patent Intelligence

... Documents and national registers is provided at no additional charge. insulin aspart - comprehensive patent search used by the world's leading pharmaceutical companies and legal teams ...

Insulin Glargine  - Comprehensive patent search

Insulin Glargine - Comprehensive patent search

  • $ 10 118
  • Company report
  • July 2014
  • by Ark Patent Intelligence

... Documents and national registers is provided at no additional charge. insulin glargine - comprehensive patent search used by the world's leading pharmaceutical companies and legal teams ...

Insulin Lispro  - Comprehensive patent search

Insulin Lispro - Comprehensive patent search

  • $ 10 118
  • Company report
  • July 2014
  • by Ark Patent Intelligence

... Documents and national registers is provided at no additional charge. insulin lispro - comprehensive patent search used by the world's leading pharmaceutical companies and legal teams ...

Insuline Medical Ltd

Insuline Medical Ltd

  • $ 55
  • Company report
  • July 2014
  • by Wright Investors' Service

... insuline medical ltd a textual analysis of the financial results for insuline medical ltd compared to selected competitors. Also included are quantitative analyses of the company's financial ...

Vildagliptin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Vildagliptin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • July 2014
  • by Ark Patent Intelligence

... A thiazolidinedione or insulininnovator:novartis (galvus, jalra, icandra, xiliarx, zomarist, eucreas, sobrea, galvumet)country coverage:# australia# canada# france # germany ...

Insulin Like Growth Factor 2 (IGF-2) Inhibitors -Pipeline Insights, 2014

Insulin Like Growth Factor 2 (IGF-2) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

... insulin like growth factor 2 (igf-2) inhibitors -pipeline insights, 2014 insulin like growth factor 2 (igf-2) inhibitors -pipeline insights, 2014 ...

Insulin Like Growth Factor (IGF) Inhibitors -Pipeline Insights, 2014

Insulin Like Growth Factor (IGF) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

... Comprehensive insights about pipeline drugs across this mechanism of action (moa). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under insulin like growth ...

Insulin Like Growth Factor 1 (IGF-1) Activators -Pipeline Insights, 2014

Insulin Like Growth Factor 1 (IGF-1) Activators -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

... Comprehensive insights about pipeline drugs across this mechanism of action (moa). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under insulin like growth ...

Insulin Like Growth Factor 2 (IGF-2) Inhibitors -Pipeline Insights, 2014

Insulin Like Growth Factor 2 (IGF-2) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

... Comprehensive insights about pipeline drugs across this mechanism of action (moa). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under insulin like growth ...

Insulin Resistance - Pipeline Review, H1 2014

Insulin Resistance - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

... The report provides a snapshot of the global therapeutic landscape of insulin resistance- the report reviews key pipeline products under drug profile section which includes, product description, moa and r ...

About 3 700 reports for Insulin

Download Unlimited Documents from Trusted Public Sources

Global Insulin Markets

  • Opportunities and Challenges for Biosimilars: What's on the Hori...
  • January 2012
    13 pages
  • Insulin  

  • United States  

View report >

13 Companies for Insulin

Read our Company Profiles

Eli Lilly and Co.

United States

Abbott Laboratories

United States

Medtronic Inc.

United States

Lilly and Co.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.